Procaps Group S.A. (NASDAQ: PROC)
$0.5140
-0.0575 ( -12.88% ) 23.3K
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Market Data
Open
$0.5140
Previous close
$0.5715
Volume
23.3K
Market cap
$64.48M
Day range
$0.5400 - $0.6620
52 week range
$0.5000 - $4.9500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 3 | Nov 15, 2024 |
| 6-k | Form 6-K | 3 | Nov 01, 2024 |
| 6-k | Form 6-K | 1 | Oct 10, 2024 |
| 6-k | Form 6-K | 1 | Oct 08, 2024 |
| 6-k | Form 6-K | 3 | Sep 18, 2024 |
| 6-k | Form 6-K | 3 | Sep 03, 2024 |
| 6-k | Form 6-K | 1 | Aug 26, 2024 |
| 6-k | Form 6-K | 1 | Jul 10, 2024 |
| 6-k | Form 6-K | 3 | Jun 28, 2024 |
| 6-k | Form 6-K | 3 | May 20, 2024 |